Development of zidovudine-resistant HIV genotypes following postnatal prophylaxis in a perinatally infected infant.
Srinivas
R V
RV
Holden
W T
WT
Su
T
T
Flynn
P M
PM
D000284:Administration, Oral; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000032:analysis; D004352:Drug Resistance, Microbial; D005260:Female; D016655:HIV Core Protein p24 / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007963:Leukocytes, Mononuclear / Q000821:virology; D009154:Mutation; D018743:Perinatal Care; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D004279:DNA, Viral; D016655:HIV Core Protein p24; D015215:Zidovudine